Oxygenta Pharmaceutical share news and announcements
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹47.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹170 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 27 Jul 2026
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,726
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Oxygenta Pharmaceutical quarterly results
The board met on 27 Jul 2026 to consider quarterly results
Notice filed 22 Jul 2026
Oxygenta Pharmaceutical annual reports, presentations and earnings calls
The company's own documents, latest first.Oxygenta Pharmaceutical financials, year by year
Annual reports26
- Annual report, year to Mar 2026 (opens in a new tab)30 Jul 2026
- Annual report, year to Mar 2025 (opens in a new tab)28 Aug 2025
- Annual report, year to Mar 2024 (opens in a new tab)7 Sep 2024
- Annual report, year to Mar 2023 (opens in a new tab)7 Sep 2023
- Annual report, year to Mar 2022 (opens in a new tab)5 Sep 2022
21 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)9 Dec 2021
- Annual report, year to Mar 2020 (opens in a new tab)8 Dec 2020
- Annual report, year to Mar 2019 (opens in a new tab)10 Sep 2019
- Annual report, year to Mar 2018 (opens in a new tab)20 Oct 2018
- Annual report, year to Mar 2017 (opens in a new tab)12 Oct 2017
- Annual report, year to Mar 2016 (opens in a new tab)14 Oct 2016
- Annual report, year to Mar 2015 (opens in a new tab)1 Dec 2015
- Annual report, year to Mar 2014 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2010 (opens in a new tab)14 Jan 2014
- Annual report, year to Mar 2011 (opens in a new tab)14 Jan 2014
- Annual report, year to Mar 2012 (opens in a new tab)14 Jan 2014
- Annual report, year to Mar 2013 (opens in a new tab)14 Jan 2014
- Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2001 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2000 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1999 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1998 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1997 (opens in a new tab)Filing day not known
Oxygenta Pharmaceutical share news and announcements
489 announcements, routine notices left out, newest first. Page 1 of 10.
Oct 2026
1 Oct · Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Purchase Of Land
Aug 2026
Jul 2026
22 Jul · Board meeting
Meeting on 27 Jul 2026: quarterly results
May 2026
19 May · Board meeting
Meeting on 23 May 2026: audited results
Apr 2026
27 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Feb 2026
20 Feb · Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.
Jan 2026
30 Jan · Board meeting
Meeting on 4 Feb 2026: quarterly results
Dec 2025
11 Dec · Intimation Under Regulation 30 The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations') To Stock Exchanges Regarding Approval Of The Shareholders For Reclassification Of Person(S) Forming Part Of The Promoter/ Promoter Group From 'Promoter/ Promoter Group Category' To 'Public Category' Shareholder(S) Regulation 31A Of The SEBI Listing Regulations.
11 Dec · Meeting
11 Dec · Meeting
Nov 2025
11 Nov · Meeting
3 Nov · Board meeting
Meeting on 7 Nov 2025: quarterly results
Oct 2025
22 Oct · Disclosure Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Sep 2025
Aug 2025
29 Aug · Intimation Of Submission Of Application For Reclassification Of Person Forming Part Of The Promoter / Promoter Group From 'Promoter Group Category To Public Category' Shareholder Of The Company Pursuant To Regulation 31A Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')
25 Aug · Board meeting
Meeting on 25 Aug 202525 Aug · Intimation Under Regulation 31A Of The SEBI (LODR) Regulations, 2015 For Reclassification From 'Promoter /Promoter Group' To 'Public'
25 Aug · Board meeting
19 Aug · Intimation Of Receipt Of Request Applications From Promoters For Reclassification In Accordance With Regulation 31A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations, 2015')
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 28 Jul 2026Board or managers changeddown 2.15%−2.0 pts vs Nifty 500market median 0.0% · five sessions −3.3% (−6.1 pts vs Nifty 500) · volume 1.6× usual · The announcement (opens in a new tab)
- 25 May 2026Board or managers changeddown 2.98%−4.2 pts vs Nifty 500market median 0.0% · five sessions −6.0% (−5.0 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
- 10 Nov 2025Board or managers changeddown 3.33%−3.7 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−7.0 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 19 Aug 2025Board or managers changeddown 4.59%−5.2 pts vs Nifty 500market median 0.0% · five sessions −7.1% (−7.6 pts vs Nifty 500) · volume 1.7× usual · The announcement (opens in a new tab)
- 18 Aug 2025Board or managers changeddown 1.91%−3.0 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−10.7 pts vs Nifty 500) · volume 6.6× usual · The announcement (opens in a new tab)
- 23 Jun 2025Board or managers changedup 3.17%+3.3 pts vs Nifty 500market median 0.0% · five sessions +5.5% (+3.0 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
- 3 Oct 2024Board or managers changedup 5.00%+7.1 pts vs Nifty 500market median 0.0% · five sessions +20.4% (+23.2 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
- 15 Feb 2024Board or managers changeddown 2.03%−2.6 pts vs Nifty 500market median 0.0% · five sessions +4.8% (+3.7 pts vs Nifty 500) · volume 1.5× usual · The announcement (opens in a new tab)
- 5 Sep 2023Board or managers changed0.00%−0.4 pts vs Nifty 500market median 0.0% · five sessions +2.2% (−0.5 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 14 Aug 2023Board or managers changeddown 4.99%−4.8 pts vs Nifty 500market median 0.0% · five sessions −18.1% (−18.0 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
5 earlier announcements
- 3 Jul 2023Board or managers changeddown 2.53%−3.1 pts vs Nifty 500market median 0.0% · five sessions +3.7% (+2.9 pts vs Nifty 500) · volume 1.1× usual · The announcement (opens in a new tab)
- 8 Dec 2021Board or managers changeddown 4.89%−6.5 pts vs Nifty 500market median 0.0% · five sessions −3.9% (−5.3 pts vs Nifty 500) · volume 0.5× usual · The announcement (opens in a new tab)
- 30 Apr 2019Board or managers changed–market median 0.0% · volume 0.0× usual · The announcement (opens in a new tab)
- 16 Jan 2018Board or managers changeddown 0.43%0.0 pts vs Nifty 500market median 0.0% · five sessions +19.5% (+17.4 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
- 6 Mar 2017Board or managers changed–market median 0.0% · volume 0.3× usual · The announcement (opens in a new tab)
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Earnings per share, continuing businesses | Year to date to Dec 2024 | Standalone | 2.27 | −2.27 | −200.0% | 15 Feb 2025 (opens in a new tab) | 17 Feb 2025 (opens in a new tab) |
| Earnings per share, continuing businesses | Quarter to Dec 2024 | Standalone | 1.07 | −1.07 | −200.0% | 15 Feb 2025 (opens in a new tab) | 17 Feb 2025 (opens in a new tab) |
| Diluted earnings per share, continuing businesses | Year to date to Dec 2024 | Standalone | 2.27 | −2.27 | −200.0% | 15 Feb 2025 (opens in a new tab) | 17 Feb 2025 (opens in a new tab) |
| Diluted earnings per share, continuing businesses | Quarter to Dec 2024 | Standalone | 1.12 | −1.12 | −200.0% | 15 Feb 2025 (opens in a new tab) | 17 Feb 2025 (opens in a new tab) |
| Earnings per share | Year to date to Dec 2024 | Standalone | 2.27 | −2.27 | −200.0% | 15 Feb 2025 (opens in a new tab) | 17 Feb 2025 (opens in a new tab) |
| Earnings per share | Quarter to Dec 2024 | Standalone | 1.07 | −1.07 | −200.0% | 15 Feb 2025 (opens in a new tab) | 17 Feb 2025 (opens in a new tab) |
| Diluted earnings per share | Year to date to Dec 2024 | Standalone | 2.27 | −2.27 | −200.0% | 15 Feb 2025 (opens in a new tab) | 17 Feb 2025 (opens in a new tab) |
| Diluted earnings per share | Quarter to Dec 2024 | Standalone | 1.12 | −1.12 | −200.0% | 15 Feb 2025 (opens in a new tab) | 17 Feb 2025 (opens in a new tab) |